Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Early outgrowth cells release soluble endocrine antifibrotic factors that reduce progressive organ fibrosis.

Yuen DA, Connelly KA, Zhang Y, Advani SL, Thai K, Kabir G, Kepecs D, Spring C, Smith C, Batruch I, Kosanam H, Advani A, Diamandis E, Marsden PA, Gilbert RE.

Stem Cells. 2013 Nov;31(11):2408-19. doi: 10.1002/stem.1502.

2.

Culture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanism.

Yuen DA, Connelly KA, Advani A, Liao C, Kuliszewski MA, Trogadis J, Thai K, Advani SL, Zhang Y, Kelly DJ, Leong-Poi H, Keating A, Marsden PA, Stewart DJ, Gilbert RE.

PLoS One. 2010 Mar 4;5(3):e9543. doi: 10.1371/journal.pone.0009543.

3.

Repeated treatment with bone marrow cell secretory products maintains long-term renoprotection in experimental chronic kidney disease: a placebo-controlled trial.

Yuen DA, Kepecs DM, Zhang Y, Advani S, Thai K, Connelly KA, Gilbert RE.

Can J Kidney Health Dis. 2015 Nov 14;2:44. doi: 10.1186/s40697-015-0082-5. eCollection 2015.

4.

Conditioned Medium from Early-Outgrowth Bone Marrow Cells Is Retinal Protective in Experimental Model of Diabetes.

Duarte DA, Papadimitriou A, Gilbert RE, Thai K, Zhang Y, Rosales MA, Lopes de Faria JB, Lopes de Faria JM.

PLoS One. 2016 Feb 2;11(2):e0147978. doi: 10.1371/journal.pone.0147978. eCollection 2016.

5.

Application of Modular Therapy for Renoprotection in Experimental Chronic Kidney Disease.

Kepecs DM, Zhang Y, Thai K, Advani SL, Yuen DA, Connelly KA, Kosanam H, Diamandis E, Sefton MV, Gilbert RE.

Tissue Eng Part A. 2015 Jul;21(13-14):1963-72. doi: 10.1089/ten.TEA.2014.0017. Epub 2015 Mar 20.

PMID:
25661544
6.

Intraparenchymal injection of bone marrow mesenchymal stem cells reduces kidney fibrosis after ischemia-reperfusion in cyclosporine-immunosuppressed rats.

Alfarano C, Roubeix C, Chaaya R, Ceccaldi C, Calise D, Mias C, Cussac D, Bascands JL, Parini A.

Cell Transplant. 2012;21(9):2009-19. doi: 10.3727/096368912X640448. Epub 2012 Apr 17.

PMID:
22525800
7.

Bone Marrow-Derived Mesenchymal Stem Cells and Their Conditioned Medium Attenuate Fibrosis in an Irreversible Model of Unilateral Ureteral Obstruction.

da Silva AF, Silva K, Reis LA, Teixeira VP, Schor N.

Cell Transplant. 2015;24(12):2657-66. doi: 10.3727/096368915X687534. Epub 2015 Feb 18.

PMID:
25695732
8.

Transforming growth factor-β1 promotes homing of bone marrow mesenchymal stem cells in renal ischemia-reperfusion injury.

Si X, Liu X, Li J, Wu X.

Int J Clin Exp Pathol. 2015 Oct 1;8(10):12368-78. eCollection 2015.

9.

Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure.

Li L, Zhang S, Zhang Y, Yu B, Xu Y, Guan Z.

Mol Biol Rep. 2009 Apr;36(4):725-31. doi: 10.1007/s11033-008-9235-2. Epub 2008 Mar 27.

PMID:
18368514
10.
11.

Improvement of liver fibrosis by infusion of cultured cells derived from human bone marrow.

Tanimoto H, Terai S, Taro T, Murata Y, Fujisawa K, Yamamoto N, Sakaida I.

Cell Tissue Res. 2013 Dec;354(3):717-28. doi: 10.1007/s00441-013-1727-2. Epub 2013 Oct 9.

PMID:
24104560
12.

Bone marrow-derived mesenchymal stem cells repaired but did not prevent gentamicin-induced acute kidney injury through paracrine effects in rats.

Reis LA, Borges FT, Simões MJ, Borges AA, Sinigaglia-Coimbra R, Schor N.

PLoS One. 2012;7(9):e44092. doi: 10.1371/journal.pone.0044092. Epub 2012 Sep 6.

13.

Progenitor-like cells derived from mouse kidney protect against renal fibrosis in a remnant kidney model via decreased endothelial mesenchymal transition.

Chen CL, Chou KJ, Fang HC, Hsu CY, Huang WC, Huang CW, Huang CK, Chen HY, Lee PT.

Stem Cell Res Ther. 2015 Dec 2;6:239. doi: 10.1186/s13287-015-0241-8.

14.

Influence of erythropoietin on microvesicles derived from mesenchymal stem cells protecting renal function of chronic kidney disease.

Wang Y, Lu X, He J, Zhao W.

Stem Cell Res Ther. 2015 May 22;6:100. doi: 10.1186/s13287-015-0095-0.

15.

Angiogenic dysfunction in bone marrow-derived early outgrowth cells from diabetic animals is attenuated by SIRT1 activation.

Yuen DA, Zhang Y, Thai K, Spring C, Chan L, Guo X, Advani A, Sivak JM, Gilbert RE.

Stem Cells Transl Med. 2012 Dec;1(12):921-6. doi: 10.5966/sctm.2012-0026. Epub 2012 Nov 26.

16.

Bone marrow-derived mesenchymal stem cell transplantation for chronic spinal cord injury in rats: comparative study between intralesional and intravenous transplantation.

Kim JW, Ha KY, Molon JN, Kim YH.

Spine (Phila Pa 1976). 2013 Aug 1;38(17):E1065-74. doi: 10.1097/BRS.0b013e31829839fa.

PMID:
23629485
17.

Bone marrow-derived cells contribute to fibrosis in the chronically failing heart.

Chu PY, Mariani J, Finch S, McMullen JR, Sadoshima J, Marshall T, Kaye DM.

Am J Pathol. 2010 Apr;176(4):1735-42. doi: 10.2353/ajpath.2010.090574. Epub 2010 Feb 11.

18.

Conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation.

Chang JW, Tsai HL, Chen CW, Yang HW, Yang AH, Yang LY, Wang PS, Ng YY, Lin TL, Lee OK.

J Cell Mol Med. 2012 Dec;16(12):2935-49. doi: 10.1111/j.1582-4934.2012.01610.x.

19.

Mesenchymal stem cells suppress fibroblast proliferation and reduce skin fibrosis through a TGF-β3-dependent activation.

Wu Y, Peng Y, Gao D, Feng C, Yuan X, Li H, Wang Y, Yang L, Huang S, Fu X.

Int J Low Extrem Wounds. 2015 Mar;14(1):50-62. doi: 10.1177/1534734614568373.

PMID:
25858630
20.

Healthy bone marrow cells reduce progression of kidney failure better than CKD bone marrow cells in rats with established chronic kidney disease.

van Koppen A, Joles JA, Bongartz LG, van den Brandt J, Reichardt HM, Goldschmeding R, Nguyen TQ, Verhaar MC.

Cell Transplant. 2012;21(10):2299-312. doi: 10.3727/096368912X636795.

PMID:
23231961

Supplemental Content

Support Center